TScan Therapeutics, Inc.
TCRX • NASDAQ • Stock Fundamentals
TScan Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gavin MacBeath, with a market cap of $60.4M.
Market Cap$60.4M
Employees154.0
CEOGavin MacBeath
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
TScan Therapeutics, Inc. FAQ
Common questions about TScan Therapeutics, Inc.
TScan Therapeutics, Inc. (TCRX) has a market capitalization of $60.4M and trades on NASDAQ.
TScan Therapeutics, Inc. has approximately 154 employees.